Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.75% to 10739.01, DAX +1.07% to 25575.01, CAC40 +0.92% to 8138.94, STOXX 600 +1.02% to 641.93

Sep 21 ,2026

  • Synopsis:

    • European equity markets finished higher on Monday, just below session highs. Industrials, banks and technology the best performers; energy, utilities and miners the big laggards. Follows third consecutive weekly loss for Stoxx 600 last week. US equity markets higher. Bonds firmer. Treasuries stronger with yields down 4-5 bps. Bund 7 bps lower at 3.46%. Gilts down 8 bps at 5.22%. Dollar firmer. Oil down, with WTI crude ~4% lower near $92/bbl. Gold down. Oil under pressure amid Middle East supply headlines highlighting pickup in Saudi crude loadings at Persian Gulf. Industrial metals gain. Bitcoin highest since late Jan, up over 6%.

    • Focus on German politics after CDU defeat in two key elections on Sunday. Chancellor Merz vowed to stay in office despite party failing to clear 5% threshold to enter state parliament in Mecklenburg-Western Pomerania. French finance ministry said it expects record debt in 2026, near 120% of GDP. Meanwhile, Ukraine launched largest attack on Moscow since conflict in Ukraine started in 2022. Russian said it will intensify attacks in Kyiv in response. Trump pressed Zelenskiy to stop targeting Russian refineries.

    • Quiet macro calendar in Europe. Update from UK property portal Rightmove saw price of UK properties put up for sale increased by 0.7% in September, which exceeded long-run average for the month. Weekend press saw speculation on UK Budget, with reports that PM Burnham and Chancellor Healey are looking at a proposal to raise capital gains tax as high as 45% to fund a handout for lower earners. Projections by KPMG on the outlook showed £12B wiped out from fiscal headroom due to Iran conflict.

    • On the corporate front, Novo Nordisk (NOVO.B.DC) posted strategic ambitions for 2030 ahead of CMD; targets to deliver pipeline sales of more than DKK 150B by 2035 and to increase its obesity customers 10 times. Kuehne & Nagel (KNIN.SW) announced a long-term logistics partnership with Amazon (AMZN) supporting AWS infrastructure construction, deployment and maintenance.

    • Societe Generale (GLE.FP) targets 13-14% RoTE by 2029 and above 15% from 2030. Volvo Car (VOLCAR.B.SS) appointed Klaus Zellmer as CEO, replacing Samuelsson by 1-Oct-27. Porsche (P911.GR) CEO ruled out further job cuts. Ipsen (IPN.FP) faces increased pressure after Amneal received US approval for a generic lanreotide.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Ind Goods & Svcs +1.84%, Banks +1.71%, Technology +1.71%, Telecom +1.18%, Construct & Mtls +1.17%, Travel & Leisure +1.14%, Chemicals +1.13%, Financial Svcs +1.12%

      • Underperformers:

        • Oil & Gas (0.76%), Utilities +0.05%, Basic Resources +0.19%, Autos & Parts +0.39%, Health Care +0.53%, Media +0.57%, Persnl & HHold Goods +0.59%, Retail +0.60%, Real Estate +0.60%, Insurance +0.71%, Food & Beverage +0.81%

    • Macro:

      • Germany:

        • Merz clings on after German election 'disaster' (Reuters , FT )

        • German Economic Institute lifts 2026 growth forecast to nearly 1.2% (Reuters)

        • Bundesbank monthly report for September highlighted economy likely to lose momentum in Q3

      • Central Banks:

        • Fed and BoE step up scrutiny of bank exposure to trading firms after Jane Street loss (FT )

        • ECB launches key link between blockchain and euro payment system (Bloomberg )

      • EU pressures Big Tech to go green with new data center sustainability label (Politico )

    • Peripheral markets:

      • Italy:

        • Meloni's proposal to set limit on foreign pupils comes under fire (ANSA )

      • Spain:

        • PM's wife to face trial over influence peddling, embezzlement allegations (Politico )

      • Denmark:

        • Denmark says NATO shares responsibility for Arctic security under Greenland deal (Reuters)

    • Company news:

      • Notable Gainers

        • +9.5% IBT.B.SS (Infant Bacterial Therapeutics SEK71.20, +6.20) -- type B Pre-BLA meeting for IBP-9414 granted by FDA

        • +6.2% KAP.LN (Kazatomprom £68.70, +4.00) -- Kyzyltu block expl. Rights, update on acid from Russia

        • +4.7% BOR.LN (Borders & Southern Petroleum £0.11, +0.01) -- H1 earnings

        • +4.3% LOTB.BB (Lotus Bakeries €12,480.00, +520.00) -- initiated buy at Jefferies

        • +4.3% BAMI.IM (Banco BPM €16.38, +0.68) -- UniCredit (UCG.IM) and Crédit Agricole (ACA.FP) considering a coordinated approach involving Banca del Mezzogiorno and Cassa di Risparmio di Orvieto

        • +4.2% KNIN.SW (Kuehne & Nagel CHF224.80, +9.10) -- long-term strategic collaboration with Amazon

        • +4.0% MAERSK.B.DC (Maersk DKK23,490.00, +900.00) -- Fearnley upgrade

        • +3.2% PEUG.FP (Peugeot Invest €52.30, +1.60) -- $175M stake in Mérieux NutriSciences

        • +1.8% GLE.FP (Societe Generale €73.87, +1.28) -- 2029 strategic plan

        • +0.4% JD.LN (JD Sports Fashion £0.74, -0.00) -- enters Mexico with Grupo Axo partnership

      • Notable Decliners

        • -50.0% MTC.LN (Mothercare £0.00, -0.00) -- financial outlook update

        • -25.8% CRW.LN (Craneware £9.96, -3.46) -- FY earnings

        • -11.7% AXS.LN (Accsys Technologies £0.63, -0.08) -- 5M trading update

        • -7.7% NOVO.B.DC (Novo Nordisk DKK260.00, -21.55) -- targets launch of >5 multi-blockbusters by 2030 and delivery of >DKK 150B pipeline sales in 2035 -- CMD; announces topline results from phase 3 REIMAGINE 5 and REDEFINE 9 trials of once-weekly CagriSema

        • -5.1% IPN.FP (Ipsen €147.90, -8.00) -- Amneal Pharmaceuticals (AMRX) FDA approval and launch of lanreotide injection

        • -3.4% PAH3.GR (Porsche Automobil Holding SE €27.46, -0.96) -- Kepler Cheuvreux downgrade

        • -2.0% AYV.FP (Ayvens €10.26, -0.21) -- 2029 strategic plan

        • -2.0% VOW3.GR (Volkswagen €74.98, -1.54) -- profit warning

        • -1.5% UPM.FH (UPM-Kymmene €25.68, -0.39) -- EC to veto UPM-Kymmene-Sappi paper JV - Reuters

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: EXOR (EXO.NA)

        • DACHs: Newron Pharmaceuticals (NWRN.SW)

        • France: ABC arbitrage (ABCA.FP), Latecoere (LAT.FP)

        • Southern Europe: Italian Wine Brands (IWB.IM)

        • UK: Smiths Group (SMIN.LN), Kingfisher (KGF.LN), OXB (OXB.LN), Luceco (LUCE.LN), PureTech Health (PRTC.LN), Yu Group (YU.LN), Mortgage Advice Bureau (MAB1.LN), Henry Boot (BOOT.LN), M&C Saatchi (SAA.LN), Fonix Plc (FNX.LN), Midwich Group (MIDW.LN), Diaceutics (DXRX.LN), Microlise Group Holdings (SAAS.LN)

        • Other: Origin Enterprises (OIZ.ID)

      • Trading Update:

        • DACHs: TUI Group (TUI1.GR)

        • UK: Sthree (STEM.LN)

  • Data:

    • Economics:

      • None today

    • Markets:

      • WTI Crude (Oct 26): ($4.82) or (4.81%) to $95.48

      • €-$ (0.0017) or (0.15%) to 1.1469

      • £-$ (0.0016) or (0.12%) to 1.3372

      • €-£ (0.0002) to 0.8578

      • S&P 500 +1.19%

      • Performance year-to-date

        • FTSE 100: +8.13%

        • DAX: +4.43%

        • CAC: (0.13%)

        • MIB: +16.52%

        • Stoxx 600: +8.40%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.